Mitofusin 2, a mitochondria-ER tethering protein, facilitates osteoclastogenesis by regulating the calcium-calcineurin-NFATc1 axis
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 516 (1) , 202-208
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF-2017R1A2A1A17069648, NRF-2018R1A5A2024418, NRF- 2018R1D1A1B07051320)
This publication has 34 references indexed in Scilit:
- Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone CellsBioMed Research International, 2015
- NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubismJournal of Clinical Investigation, 2008
- Bone Biology and the Clinical Implications for OsteoporosisPhysical Therapy, 2006
- Essential Role of p38 Mitogen-activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1Journal of Biological Chemistry, 2004
- Osteoclast differentiation and activationNature, 2003
- Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of OsteoclastsDevelopmental Cell, 2002
- Age-Related Decline in Osteoprotegerin Expression by Human Bone Marrow Cells Cultured in Three-Dimensional Collagen SpongesBiochemical and Biophysical Research Communications, 2000
- Cell biology of the osteoclastExperimental Hematology, 1999
- Activation of NF-κB by RANK Requires Tumor Necrosis Factor Receptor-associated Factor (TRAF) 6 and NF-κB-inducing KinaseJournal of Biological Chemistry, 1999
- Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLProceedings of the National Academy of Sciences, 1998